CELL INTELLIGENCE · 肿瘤细胞治疗研究

CDK12 的泛癌多组学特征分析及越南天然产物新型抑制剂的虚拟筛选

Pan-cancer multi-omics characterization of CDK12 and virtual screening of Vietnamese natural products for novel inhibitors.

S1PR1 受体在多种人类癌症中的生物信息学探索及其临床相关性

Bioinformatics exploration of the S1PR1 receptor in various human cancers and its clinical relevance.

S1PR1 通过其表达、突变和修饰在癌症进展中发挥关键作用。这些发现表明，S1PR1 可作为癌症潜在的生物标志物和治疗靶点，但需要在临床环境中进一步验证。

Nemvaleukin alfa，一种修饰的白细胞介素-2 细胞因子，作为单药治疗以及与 pembrolizumab 联合治疗晚期实体瘤患者（ARTISTRY-1）

Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1).

Nemvaleukin 耐受性良好，并在经过大量预治疗的晚期实体瘤中显示出有前景的抗肿瘤活性。Nemvaleukin 的 2/3 期研究正在进行中。

多腔微孔芯片中药物和免疫敏感性的微型化多重高内涵筛选

Miniaturized and multiplexed high-content screening of drug and immune sensitivity in a multichambered microwell chip.

CAR-T 细胞：从原理到临床应用

CAR-T cells, from principle to clinical applications.